Inmedix

About:

Inmedix brings cloud-based clinical diagnostics and immuno-autonomics to medicine to improve outcomes in autoimmune diseases and beyond.

Website: https://inmedix.com/

Top Investors: Keiretsu Capital, Keiretsu Forum Northwest, K4 Forum Mumbai Network

Description:

Inmedix has discovered and is commercializing a novel class of diagnostics and therapeutics. Their approach focuses on autonomic nervous system (ANS) control of stress responses within the brain. In the setting of an autoimmune disease, ANS stress can significantly intensify an autoimmune disease. They call it Immuno-autonomics. They seek to understand and block this process to allow current autoimmune disease therapies to work much better.